Proteome Sciences Pl (PMSNF) 0.5200 $PMSNF
Concise Analysis of the International Cancer/Tumor Profiling Market - Forecasts to 2018
M2 - Tue Mar 11, 6:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9dp8rj/cancertumor) has announced the addition of the "Concise Analysis of the International Cancer/Tumor Profiling Market - Forecasts to 2018" report to their offering. The global tumor profiling market is anticipated to reach $35.03 billion by 2018 growing at a CAGR of 18.50%. The market is divided by geography (North America, Europe, Asia-Pacific, and Rest of the World), applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, and Research Applications), technologies (Next-Generation Sequencing, Quantitative PCR, Immunohistochemistry, FISH/CISH, and Microarray) and segments (Genomics, Proteomics, Metabolomics, and Epigenetics). Further, each application, technology, and segment type is broken down by geography, with an exhaustive revenue analysis for the entire forecast period. Of the above mentioned applications, Personalized Medicine is the largest revenue sector and will be the fastest-growing segment. The cancer profiling market is driven mainly by the rising number of cancer cases. Technological advancements to identify the exact cause of the condition are considered as the second major driver. Additionally, demand for safer and cost-effective treatment further drives the market. The rapid growth of the tumor profiling market is attributed to its promising application in personalized cancer therapy; and its extension in early diagnosis, disease prognosis, and research applications will further enhance its market growth. The current approach of cancer profiling in targeted therapy and personalized medicine for cancer has the potential to address the current demands and fill the gaps in the healthcare industry. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Tumor Profiling Technology Landscape 4 Tumor Profiling Research Portfolio 5 Value Chain Analysis 6 Market Landscape Analysis 7 Technology Adoption And Development Potential, By Geography 8 Technology Investment Analysis 9 Competitive Landscape Analysis 10 Patent Analysis 11 Analyst Insights And Recommendations 12 Company Profiles Companies Mentioned: - Agendia Nv - Biotheranostics - Boreal Genomics, Inc - Caris Life Sciences - Genomic Health, Inc - Illumina, Inc - Life Technologies Corporation - Nanostring Technologies - Neogenomics Laboratories - Oncopath Laboratory - Oxford Gene Technology Ltd - Precision Therapeutics, Inc - Proteome Sciences Plc - Rational Therapeutics - Ribomed Biotechnologies For more information visit http://www.researchandmarkets.com/research/9d...ancertumor
2014 Automated Microbiology Market -- A Global Strategic Outlook: Molecular Diagnostics, Microbial Identification, Blood Culture, Urine Screening and Immunodiagnostics
M2 - Tue Feb 18, 8:31AM CST
Research and Markets (http://www.researchandmarkets.com/research/48jvmv/2014_automated) has announced the addition of the "2014 Automated Microbiology Market -- A Global Strategic Outlook: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics" report to their offering. '2014 Automated Microbiology Market--A Global Strategic Outlook' is a new seven-country strategic analysis of the major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment, and country; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. This comprehensive seven-country report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies. Worldwide Market Overview - Estimated universe of laboratories performing microbiology testing by country. - Specimen, test volume and sales forecasts by country. Market Segmentation Analysis - Sales and market shares for major suppliers by individual test and country. - Volume and sales forecasts for over 100 infectious disease assays by individual test and country. - Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy). - Review of the market dynamics, trends, structure, size, growth and major suppliers by country Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Caliper - Cepheid - Decode - Diadexus - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Exact Sciences - Fujirebio/Innogenetics - Hologic/Gen-Probe - Illumina - ID Biomedical/GSK - Kreatech - Li-Cor Biosciences - Life Technology - Lonza - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Novartis Diagnostics/Grifols - Orchid CellMark - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Sierra Molecular - Shimadzu - Takara Bio - Tecan - Thermo Fisher - Wallac/PE - Wako For more information visit http://www.researchandmarkets.com/research/48..._automated About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
2013 Report on the International Biomarkers Market - Includes Forecasts to 2018
M2 - Thu Dec 19, 4:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/jjq7jz/biomarkers_market) has announced the addition of the "2013 Report on the International Biomarkers Market - Includes Forecasts to 2018" report to their offering. Biomarkers comprise definite cells, genes, molecules, gene products, enzymes, or hormones which are objectively measured as an indicator of typical biological processes, pathogenic processes, or pharmacologic response to a therapeutic intrusion. Major application areas of biomarkers are early disease diagnosis and prevention, drug target recognition, and drug discovery and development. The global market showcases high growth potential in the near future. This market is expected to grow at a CAGR of 18.5% from 2013 to 2018, to reach $40.8 billion by 2018. The key players in this market are Roche Diagnostics Limited (Switzerland), Johnson & Johnson (U.S.), GlaxoSmithKline, Plc. (U.K.), Siemens Healthcare (Germany), Abbott Laboratories, Inc. (U.S.), GE Healthcare (U.K.), Affymetrix, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Epigenomics AG (Germany), Eisai Co. Ltd. (Japan), Bio-Rad Laboratories, Inc. (U.S.), Eli Lilly and Company (U.S.), Merck & Co. (U.S.), Genomic Health, Inc. (U.S.), and Agilent Technologies Inc. (U.S.) Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Biomarkers Market, By Discovery Technologies 5 Services Market Of Biomarkers 6 Biomarkers Application Market 7 Biomarkers Indication Market 8 Geographical Analysis 9 Competitive Landscape 10 Company Profiles Companies Mentioned: - Abbott Laboratories - BGI - Bayer Ag - Bristol-Myers Squibb - Caprion Proteomics Inc - Crescendo Bioscience - Eisai Co Ltd - Epiontis GMBH - Epistem Holdings PLC - Eurogentec SA - Evotec AG - Glaxosmithkline PLC - Ipsen - Johnson & Johnson - Merck & Co - Micromedic Technologies Ltd - Myriad Genetics Inc - Nextgen Sciences Inc - Novartis International AG - Ocimum Biosolutions Ltd - Pacific Biomarkers Inc - Pfizer Inc - Pronota NV - Proteome Sciences Plc - Qiagen Nv - Quintiles Transnational Corporation - Roche Diagnostics Limited - Sanofi-Aventis - Siemens Healthcare - Trans-Hit Biomarkers Inc - Vermillion Inc For more information visit http://www.researchandmarkets.com/research/jj...ers_market
Global Cancer Profiling Market Report 2013 - 2018
M2 - Wed Dec 04, 5:18AM CST
Research and Markets (http://www.researchandmarkets.com/research/p3lcfj/cancertumor) has announced the addition of the "Global Cancer Profiling Market Report 2013 - 2018" report to their offering. Cancer profiling is witnessing significant growth in the healthcare industry. It is poised to grow rapidly in a range of application areas, including biomarker discovery and prognosis. The global market is valued at $14.99 billion in 2013 and is expected to reach $35.03 billion by 2018. A range of tests (Barium X-ray, Blood tests, Bone marrow, Cystoscopy, Lumbar puncture etc.) are used for diagnosing specific types of cancer. A host of different treatment options for cancer, including chemotherapy, hormone therapy, surgery, radiotherapy, bisphosphonates, bone marrow and stem cell transplants, and biological therapies are also available. Despite the availability of different treatment options, profiling a tumor - that is, knowledge about a patient's cancer profile - may identify genomic alterations that will help the physician to guide the patient to a systemic therapy with a higher likelihood of success. This will rule out those that are unlikely to be successful, on an individual basis, thereby minimizing the trial and error process. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Tumor Profiling Technology Landscape 4 Tumor Profiling Research Portfolio 5 Value Chain Analysis 6 Market Landscape Analysis 7 Technology Adoption And Development Potential, By Geography 7.1 Geographic Adoption And Development Potential - Overview 7.2 North America 7.3 Europe 7.4 Asia 7.5 Rest Of The World (ROW) 8 Technology Investment Analysis 9 Competitive Landscape Analysis 9.1 Competitive Landscape Analysis 9.2 Key Acquisitions/Partnerships/Agreements/Collaborations (2010-2013) 9.3 Technologies Available For Licensing & Acquisition For Stakeholders 10 Patent Analysis 11 Analyst Insights And Recommendations 11.1 Key Insights On The Market 11.2 Strategic Recommendations 11.3 Open Opportunity Invitations In The Field For Business Development 12 Company Profiles Companies Mentioned: - Agendia - Biotheranostics - Boreal Genomics - Caris Life Sciences - Genomic Health - Illumina - Life Technologies Corporation - Nanostring Technologies - Neogenomics Laboratories - Oncopath Laboratory - Oxford Gene Technology - Precision Therapeutics - Proteome Sciences - Rational Therapeutics - Ribomed Biotechnologies For more information visit http://www.researchandmarkets.com/research/p3...ancertumor
2014 Opportunities in the US Blood Banking Market
M2 - Tue Sep 10, 10:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3n5fm8/2014) has announced the addition of the "2014 Opportunities in the US Blood Banking Market" report to their offering. 2014 Opportunities in the US Blood Banking Market is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the US blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the US; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. U.S.A. VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/3n5fm8/2014
2014 Opportunities in the Spanish Blood Banking Market
M2 - Tue Sep 10, 10:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jksfrr/2014) has announced the addition of the "2014 Opportunities in the Spanish Blood Banking Market" report to their offering. 2014 Opportunities in the Spanish Blood Banking Market is a new strategic analysis prepared in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the Spanish blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the Spain; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Sales and Market Share Analysis Sales and market share estimates of leading suppliers of blood banking of reagents and instruments, by individual product. Competitive Assessments Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. Spain VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/jksfrr/2014
2014 Opportunities in the Italian Blood Banking Market
M2 - Tue Sep 10, 10:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2xh39t/2014) has announced the addition of the "2014 Opportunities in the Italian Blood Banking Market" report to their offering. 2014 Opportunities in the Italian Blood Banking Market is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the Italian blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the Italy; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Sales and Market Share Analysis Sales and market share estimates of leading suppliers of blood banking of reagents and instruments, by individual product. Competitive Assessments Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview 2. Infectious Disease Screening Tests C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. Italy VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/2xh39t/2014
2014 Opportunities in the Japanese Blood Banking Market
M2 - Tue Sep 10, 9:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6pm3km/2014) has announced the addition of the "2014 Opportunities in the Japanese Blood Banking Market" report to their offering. 2014 Opportunities in the Japanese Blood Banking Market is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the Japanese blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the Japan; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Sales and Market Share Analysis Sales and market share estimates of leading suppliers of blood banking of reagents and instruments, by individual product. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview 2. Infectious Disease Screening Tests B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. Japan VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/6pm3km/2014
2014 Opportunities in the German Blood Banking Market
M2 - Tue Sep 10, 9:52AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7hrmr8/2014) has announced the addition of the "2014 Opportunities in the German Blood Banking Market" report to their offering. 2014 Opportunities in the German Blood Banking Market is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the German blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the Germany; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Sales and Market Share Analysis Sales and market share estimates of leading suppliers of blood banking of reagents and instruments, by individual product. Competitive Assessments Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. Germany VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/7hrmr8/2014
2014 Opportunities in the European Blood Banking Market
M2 - Tue Sep 10, 9:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/m72czr/2014) has announced the addition of the "2014 Opportunities in the European Blood Banking Market" report to their offering. 2014 Opportunities in the European Blood Banking Market is a new five-country strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the European blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Key Topics Covered: I.Introduction II. Major Product Development Opportunities A. Blood Typing and Grouping B. Infectious Disease Screening C. Auxiliary III. Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts IV. Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection V.Worldwide Technology and Market Overview B. Instrumentation Review: Operating Characteristics,Features and Selling Prices of Leading Automated and Semi automated Analyzers Manufactured C. Major in Vitro Diagnostic TechnologiesAnd Their Potential Applications VI. France VII. Germany VIII. Italy IX. Spain X. U.K. XI. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan XII. Appendix For more information visit http://www.researchandmarkets.com/research/m72czr/2014
2014 Opportunities in the French Blood Banking Market
M2 - Tue Sep 10, 9:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2rkjf7/2014) has announced the addition of the "2014 Opportunities in the French Blood Banking Market" report to their offering. 2014 Opportunities in the French Blood Banking Market is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the French blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the France; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview B. Instrumentation Review: Operating Characteristics,Features and Selling Prices of Leading Automated and Semi automated Analyzers Manufactured C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. France A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/2rkjf7/2014
2014 Opportunities in the Global Blood Banking Market
M2 - Tue Sep 10, 9:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/85v68b/2014) has announced the addition of the "2014 Opportunities in the Global Blood Banking Market" report to their offering. 2014 Opportunities in the Global Blood Banking Market is a new seven-country strategic analysis prepared in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the global blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Worldwide Market Overview - Estimates of facilities performing blood banking tests, by country. - Test volume and sales projections by country Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA The report explores future marketing and technological trends in the US, Europe and Japan; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Key Topics Covered: I Introduction II Worldwide Market Overview III. Major Product Development Opportunities IV. Alternative Market Penetration Strategies VI Worldwide Technology and Market Overview B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semi automated Analyzers Manufactured C. Major in Vitro Diagnostic Technologies And Their Potential Applications VII. France VIII. Germany IX. Italy X. Japan XI. Spain XII. U.K. XIII. U.S.A. XIV. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan XV. Appendix For more information visit http://www.researchandmarkets.com/research/85v68b/2014
UK Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies
M2 - Fri Sep 06, 8:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/sx8fw4/uk_transfusion) has announced the addition of the "UK Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the UK transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in UK; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion diagnostic products by individual product. Competitive Assessments Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview A. Major Blood Typing, Grouping and Infectious Disease Screening Tests B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers C. Major in Vitro Diagnostic Technologies and Their Potential Applications III. UK A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests IV.Major Product Development Opportunities A. Blood Typing and Grouping B. Infectious Disease Screening C. Auxiliary V. Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts VI. Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix: Assumed Currency Exchange Rates For more information visit http://www.researchandmarkets.com/research/sx...ransfusion
Japan Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies
M2 - Fri Sep 06, 8:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lbz7vl/japan_transfusion) has announced the addition of the "Japan Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the Japanese transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in Japan; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview A. Major Blood Typing, Grouping and Infectious Disease Screening Tests B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semi-automated Analyzers C. Major in Vitro Diagnostic Technologies And Their Potential Applications 1. Molecular Diagnostics 2. Monoclonal and Polyclonal Antibodies 3. Immunoassays 4. Microtitration Plates 5. IT and Automation 6. Lasers 7. Robotics 8. Synthetic Red Cell Substitutes 9. Genetically Engineered Blood Components 10. Blood Preservation 11. Autologous Blood Transfusion/Freezing III. Japan A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests IV. Major Product Development Opportunities A. Blood Typing and Grouping B. Infectious Disease Screening C. Auxiliary V. Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts VI. Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix: Assumed Currency Exchange Rates For more information visit http://www.researchandmarkets.com/research/lb...ransfusion
Spain Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies
M2 - Fri Sep 06, 8:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lpmr3t/spain_transfusion) has announced the addition of the "Spain Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the Spanish transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in Spain; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion diagnostic products by individual product. Competitive Assessments Strategic assessments of major suppliers and nemerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview A. Major Blood Typing, Grouping and Infectious Disease Screening Tests B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers C. Major in Vitro Diagnostic Technologies And Their Potential Applications 1. Molecular Diagnostics 2. Monoclonal and Polyclonal Antibodies 3. Immunoassays 4. Microtitration Plates 5. IT and Automation 6. Lasers 7. Robotics 8. Synthetic Red Cell Substitutes 9. Genetically Engineered Blood Components 10. Blood Preservation 11. Autologous Blood Transfusion/Freezing III. Spain A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares for Blood Typing, Groupingand Infectious Disease Screening Tests IV. Major Product Development Opportunities A. Blood Typing and Grouping B. Infectious Disease Screening C. Auxiliary V. Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts VI. Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix: Assumed Currency Exchange Rates For more information visit http://www.researchandmarkets.com/research/lp...ransfusion
France Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies
M2 - Fri Sep 06, 8:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hf7js5/france) has announced the addition of the "France Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the French transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in France; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion diagnostic products by individual product. Competitive Assessments Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. Market Segmentation Analysis - Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and key suppliers. - Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT, by country and market segment: - Blood Centers - Hospitals - Commercial/Private Laboratories Current and Emerging Products - Analysis of current and emerging blood typing, grouping and infectious disease screening tests. - Review of automated and semi-automated analyzers. Key Topics Covered: I.Introduction II.Worldwide Technology and Market Overview III.France A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests IV.Major Product Development Opportunities A. Blood Typing and Grouping B. Infectious Disease Screening C. Auxiliary V.Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts VI.Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection VII.Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan XII. Appendix: Assumed Currency Exchange Rates For more information visit http://www.researchandmarkets.com/research/hf7js5/france
Germany Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies
M2 - Fri Sep 06, 8:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jhzmg8/germany) has announced the addition of the "Germany Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the German transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in Germany; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion diagnostic products by individual product. Competitive Assessments Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. Market Segmentation Analysis - Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and key suppliers. - Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT, by country and market segment: - Blood Centers - Hospitals - Commercial/Private Laboratories Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview III. Germany A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests IV. Major Product Development Opportunities A. Blood Typing and Grouping B. Infectious Disease Screening C. Auxiliary V. Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts VI. Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix: Assumed Currency Exchange Rates For more information visit http://www.researchandmarkets.com/research/jhzmg8/germany
Italy Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies
M2 - Fri Sep 06, 8:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gbmfl6/italy_transfusion) has announced the addition of the "Italy Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the Italian transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in Italy; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion diagnostic products by individual product. Competitive Assessments Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview III. Italy A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests IV. Major Product Development Opportunities A. Blood Typing and Grouping B. Infectious Disease Screening C. Auxiliary V. Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts VI. Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan XII. Appendix: Assumed Currency Exchange Rates For more information visit http://www.researchandmarkets.com/research/gb...ransfusion
Global Transfusion Diagnostics Market 2013 - France, Germany, Italy, Japan, Spain, UK, USA - Sales Forecasts, Supplier Shares, Competitive Strategies
M2 - Fri Sep 06, 8:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fhzvtw/global) has announced the addition of the "Global Transfusion Diagnostics Market 2013 - France, Germany, Italy, Japan, Spain, UK, USA - Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in the US, Europe and Japan; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Geographic Regions - France - Germany - Italy - Japan - Spain - UK - USA Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview III. France IV. Germany A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests V. Italy A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests VI. Japan A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests VII. Spain A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests VIII. U.K. IX. U.S.A. X. Major Product Development Opportunities XI. Alternative Market Penetration Strategies XII. Potential Market Entry Barriers and Risks XIII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan XIV. Appendix: Assumed Currency Exchange Rates For more information visit http://www.researchandmarkets.com/research/fhzvtw/global
Concise Analysis of the International Cancer/Tumor Profiling Market - Forecasts to 2018
M2 - Tue Mar 11, 6:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9dp8rj/cancertumor) has announced the addition of the "Concise Analysis of the International Cancer/Tumor Profiling Market - Forecasts to 2018" report to their offering. The global tumor profiling market is anticipated to reach $35.03 billion by 2018 growing at a CAGR of 18.50%. The market is divided by geography (North America, Europe, Asia-Pacific, and Rest of the World), applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, and Research Applications), technologies (Next-Generation Sequencing, Quantitative PCR, Immunohistochemistry, FISH/CISH, and Microarray) and segments (Genomics, Proteomics, Metabolomics, and Epigenetics). Further, each application, technology, and segment type is broken down by geography, with an exhaustive revenue analysis for the entire forecast period. Of the above mentioned applications, Personalized Medicine is the largest revenue sector and will be the fastest-growing segment. The cancer profiling market is driven mainly by the rising number of cancer cases. Technological advancements to identify the exact cause of the condition are considered as the second major driver. Additionally, demand for safer and cost-effective treatment further drives the market. The rapid growth of the tumor profiling market is attributed to its promising application in personalized cancer therapy; and its extension in early diagnosis, disease prognosis, and research applications will further enhance its market growth. The current approach of cancer profiling in targeted therapy and personalized medicine for cancer has the potential to address the current demands and fill the gaps in the healthcare industry. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Tumor Profiling Technology Landscape 4 Tumor Profiling Research Portfolio 5 Value Chain Analysis 6 Market Landscape Analysis 7 Technology Adoption And Development Potential, By Geography 8 Technology Investment Analysis 9 Competitive Landscape Analysis 10 Patent Analysis 11 Analyst Insights And Recommendations 12 Company Profiles Companies Mentioned: - Agendia Nv - Biotheranostics - Boreal Genomics, Inc - Caris Life Sciences - Genomic Health, Inc - Illumina, Inc - Life Technologies Corporation - Nanostring Technologies - Neogenomics Laboratories - Oncopath Laboratory - Oxford Gene Technology Ltd - Precision Therapeutics, Inc - Proteome Sciences Plc - Rational Therapeutics - Ribomed Biotechnologies For more information visit http://www.researchandmarkets.com/research/9d...ancertumor
2014 Automated Microbiology Market -- A Global Strategic Outlook: Molecular Diagnostics, Microbial Identification, Blood Culture, Urine Screening and Immunodiagnostics
M2 - Tue Feb 18, 8:31AM CST
Research and Markets (http://www.researchandmarkets.com/research/48jvmv/2014_automated) has announced the addition of the "2014 Automated Microbiology Market -- A Global Strategic Outlook: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics" report to their offering. '2014 Automated Microbiology Market--A Global Strategic Outlook' is a new seven-country strategic analysis of the major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment, and country; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. This comprehensive seven-country report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies. Worldwide Market Overview - Estimated universe of laboratories performing microbiology testing by country. - Specimen, test volume and sales forecasts by country. Market Segmentation Analysis - Sales and market shares for major suppliers by individual test and country. - Volume and sales forecasts for over 100 infectious disease assays by individual test and country. - Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy). - Review of the market dynamics, trends, structure, size, growth and major suppliers by country Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Caliper - Cepheid - Decode - Diadexus - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Exact Sciences - Fujirebio/Innogenetics - Hologic/Gen-Probe - Illumina - ID Biomedical/GSK - Kreatech - Li-Cor Biosciences - Life Technology - Lonza - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Novartis Diagnostics/Grifols - Orchid CellMark - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Sierra Molecular - Shimadzu - Takara Bio - Tecan - Thermo Fisher - Wallac/PE - Wako For more information visit http://www.researchandmarkets.com/research/48..._automated About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
2013 Report on the International Biomarkers Market - Includes Forecasts to 2018
M2 - Thu Dec 19, 4:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/jjq7jz/biomarkers_market) has announced the addition of the "2013 Report on the International Biomarkers Market - Includes Forecasts to 2018" report to their offering. Biomarkers comprise definite cells, genes, molecules, gene products, enzymes, or hormones which are objectively measured as an indicator of typical biological processes, pathogenic processes, or pharmacologic response to a therapeutic intrusion. Major application areas of biomarkers are early disease diagnosis and prevention, drug target recognition, and drug discovery and development. The global market showcases high growth potential in the near future. This market is expected to grow at a CAGR of 18.5% from 2013 to 2018, to reach $40.8 billion by 2018. The key players in this market are Roche Diagnostics Limited (Switzerland), Johnson & Johnson (U.S.), GlaxoSmithKline, Plc. (U.K.), Siemens Healthcare (Germany), Abbott Laboratories, Inc. (U.S.), GE Healthcare (U.K.), Affymetrix, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Epigenomics AG (Germany), Eisai Co. Ltd. (Japan), Bio-Rad Laboratories, Inc. (U.S.), Eli Lilly and Company (U.S.), Merck & Co. (U.S.), Genomic Health, Inc. (U.S.), and Agilent Technologies Inc. (U.S.) Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Biomarkers Market, By Discovery Technologies 5 Services Market Of Biomarkers 6 Biomarkers Application Market 7 Biomarkers Indication Market 8 Geographical Analysis 9 Competitive Landscape 10 Company Profiles Companies Mentioned: - Abbott Laboratories - BGI - Bayer Ag - Bristol-Myers Squibb - Caprion Proteomics Inc - Crescendo Bioscience - Eisai Co Ltd - Epiontis GMBH - Epistem Holdings PLC - Eurogentec SA - Evotec AG - Glaxosmithkline PLC - Ipsen - Johnson & Johnson - Merck & Co - Micromedic Technologies Ltd - Myriad Genetics Inc - Nextgen Sciences Inc - Novartis International AG - Ocimum Biosolutions Ltd - Pacific Biomarkers Inc - Pfizer Inc - Pronota NV - Proteome Sciences Plc - Qiagen Nv - Quintiles Transnational Corporation - Roche Diagnostics Limited - Sanofi-Aventis - Siemens Healthcare - Trans-Hit Biomarkers Inc - Vermillion Inc For more information visit http://www.researchandmarkets.com/research/jj...ers_market
Global Cancer Profiling Market Report 2013 - 2018
M2 - Wed Dec 04, 5:18AM CST
Research and Markets (http://www.researchandmarkets.com/research/p3lcfj/cancertumor) has announced the addition of the "Global Cancer Profiling Market Report 2013 - 2018" report to their offering. Cancer profiling is witnessing significant growth in the healthcare industry. It is poised to grow rapidly in a range of application areas, including biomarker discovery and prognosis. The global market is valued at $14.99 billion in 2013 and is expected to reach $35.03 billion by 2018. A range of tests (Barium X-ray, Blood tests, Bone marrow, Cystoscopy, Lumbar puncture etc.) are used for diagnosing specific types of cancer. A host of different treatment options for cancer, including chemotherapy, hormone therapy, surgery, radiotherapy, bisphosphonates, bone marrow and stem cell transplants, and biological therapies are also available. Despite the availability of different treatment options, profiling a tumor - that is, knowledge about a patient's cancer profile - may identify genomic alterations that will help the physician to guide the patient to a systemic therapy with a higher likelihood of success. This will rule out those that are unlikely to be successful, on an individual basis, thereby minimizing the trial and error process. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Tumor Profiling Technology Landscape 4 Tumor Profiling Research Portfolio 5 Value Chain Analysis 6 Market Landscape Analysis 7 Technology Adoption And Development Potential, By Geography 7.1 Geographic Adoption And Development Potential - Overview 7.2 North America 7.3 Europe 7.4 Asia 7.5 Rest Of The World (ROW) 8 Technology Investment Analysis 9 Competitive Landscape Analysis 9.1 Competitive Landscape Analysis 9.2 Key Acquisitions/Partnerships/Agreements/Collaborations (2010-2013) 9.3 Technologies Available For Licensing & Acquisition For Stakeholders 10 Patent Analysis 11 Analyst Insights And Recommendations 11.1 Key Insights On The Market 11.2 Strategic Recommendations 11.3 Open Opportunity Invitations In The Field For Business Development 12 Company Profiles Companies Mentioned: - Agendia - Biotheranostics - Boreal Genomics - Caris Life Sciences - Genomic Health - Illumina - Life Technologies Corporation - Nanostring Technologies - Neogenomics Laboratories - Oncopath Laboratory - Oxford Gene Technology - Precision Therapeutics - Proteome Sciences - Rational Therapeutics - Ribomed Biotechnologies For more information visit http://www.researchandmarkets.com/research/p3...ancertumor
2014 Opportunities in the US Blood Banking Market
M2 - Tue Sep 10, 10:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3n5fm8/2014) has announced the addition of the "2014 Opportunities in the US Blood Banking Market" report to their offering. 2014 Opportunities in the US Blood Banking Market is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the US blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the US; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. U.S.A. VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/3n5fm8/2014
2014 Opportunities in the Spanish Blood Banking Market
M2 - Tue Sep 10, 10:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jksfrr/2014) has announced the addition of the "2014 Opportunities in the Spanish Blood Banking Market" report to their offering. 2014 Opportunities in the Spanish Blood Banking Market is a new strategic analysis prepared in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the Spanish blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the Spain; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Sales and Market Share Analysis Sales and market share estimates of leading suppliers of blood banking of reagents and instruments, by individual product. Competitive Assessments Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. Spain VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/jksfrr/2014
2014 Opportunities in the Italian Blood Banking Market
M2 - Tue Sep 10, 10:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2xh39t/2014) has announced the addition of the "2014 Opportunities in the Italian Blood Banking Market" report to their offering. 2014 Opportunities in the Italian Blood Banking Market is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the Italian blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the Italy; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Sales and Market Share Analysis Sales and market share estimates of leading suppliers of blood banking of reagents and instruments, by individual product. Competitive Assessments Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview 2. Infectious Disease Screening Tests C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. Italy VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/2xh39t/2014
2014 Opportunities in the Japanese Blood Banking Market
M2 - Tue Sep 10, 9:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6pm3km/2014) has announced the addition of the "2014 Opportunities in the Japanese Blood Banking Market" report to their offering. 2014 Opportunities in the Japanese Blood Banking Market is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the Japanese blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the Japan; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Sales and Market Share Analysis Sales and market share estimates of leading suppliers of blood banking of reagents and instruments, by individual product. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview 2. Infectious Disease Screening Tests B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. Japan VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/6pm3km/2014
2014 Opportunities in the German Blood Banking Market
M2 - Tue Sep 10, 9:52AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7hrmr8/2014) has announced the addition of the "2014 Opportunities in the German Blood Banking Market" report to their offering. 2014 Opportunities in the German Blood Banking Market is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the German blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the Germany; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Sales and Market Share Analysis Sales and market share estimates of leading suppliers of blood banking of reagents and instruments, by individual product. Competitive Assessments Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. Germany VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/7hrmr8/2014
2014 Opportunities in the European Blood Banking Market
M2 - Tue Sep 10, 9:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/m72czr/2014) has announced the addition of the "2014 Opportunities in the European Blood Banking Market" report to their offering. 2014 Opportunities in the European Blood Banking Market is a new five-country strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the European blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Key Topics Covered: I.Introduction II. Major Product Development Opportunities A. Blood Typing and Grouping B. Infectious Disease Screening C. Auxiliary III. Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts IV. Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection V.Worldwide Technology and Market Overview B. Instrumentation Review: Operating Characteristics,Features and Selling Prices of Leading Automated and Semi automated Analyzers Manufactured C. Major in Vitro Diagnostic TechnologiesAnd Their Potential Applications VI. France VII. Germany VIII. Italy IX. Spain X. U.K. XI. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan XII. Appendix For more information visit http://www.researchandmarkets.com/research/m72czr/2014
2014 Opportunities in the French Blood Banking Market
M2 - Tue Sep 10, 9:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2rkjf7/2014) has announced the addition of the "2014 Opportunities in the French Blood Banking Market" report to their offering. 2014 Opportunities in the French Blood Banking Market is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the French blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the France; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview B. Instrumentation Review: Operating Characteristics,Features and Selling Prices of Leading Automated and Semi automated Analyzers Manufactured C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. France A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/2rkjf7/2014
2014 Opportunities in the Global Blood Banking Market
M2 - Tue Sep 10, 9:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/85v68b/2014) has announced the addition of the "2014 Opportunities in the Global Blood Banking Market" report to their offering. 2014 Opportunities in the Global Blood Banking Market is a new seven-country strategic analysis prepared in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the global blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Worldwide Market Overview - Estimates of facilities performing blood banking tests, by country. - Test volume and sales projections by country Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA The report explores future marketing and technological trends in the US, Europe and Japan; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Key Topics Covered: I Introduction II Worldwide Market Overview III. Major Product Development Opportunities IV. Alternative Market Penetration Strategies VI Worldwide Technology and Market Overview B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semi automated Analyzers Manufactured C. Major in Vitro Diagnostic Technologies And Their Potential Applications VII. France VIII. Germany IX. Italy X. Japan XI. Spain XII. U.K. XIII. U.S.A. XIV. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan XV. Appendix For more information visit http://www.researchandmarkets.com/research/85v68b/2014
UK Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies
M2 - Fri Sep 06, 8:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/sx8fw4/uk_transfusion) has announced the addition of the "UK Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the UK transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in UK; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion diagnostic products by individual product. Competitive Assessments Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview A. Major Blood Typing, Grouping and Infectious Disease Screening Tests B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers C. Major in Vitro Diagnostic Technologies and Their Potential Applications III. UK A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests IV.Major Product Development Opportunities A. Blood Typing and Grouping B. Infectious Disease Screening C. Auxiliary V. Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts VI. Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix: Assumed Currency Exchange Rates For more information visit http://www.researchandmarkets.com/research/sx...ransfusion
Japan Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies
M2 - Fri Sep 06, 8:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lbz7vl/japan_transfusion) has announced the addition of the "Japan Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the Japanese transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in Japan; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview A. Major Blood Typing, Grouping and Infectious Disease Screening Tests B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semi-automated Analyzers C. Major in Vitro Diagnostic Technologies And Their Potential Applications 1. Molecular Diagnostics 2. Monoclonal and Polyclonal Antibodies 3. Immunoassays 4. Microtitration Plates 5. IT and Automation 6. Lasers 7. Robotics 8. Synthetic Red Cell Substitutes 9. Genetically Engineered Blood Components 10. Blood Preservation 11. Autologous Blood Transfusion/Freezing III. Japan A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests IV. Major Product Development Opportunities A. Blood Typing and Grouping B. Infectious Disease Screening C. Auxiliary V. Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts VI. Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix: Assumed Currency Exchange Rates For more information visit http://www.researchandmarkets.com/research/lb...ransfusion
Spain Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies
M2 - Fri Sep 06, 8:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lpmr3t/spain_transfusion) has announced the addition of the "Spain Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the Spanish transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in Spain; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion diagnostic products by individual product. Competitive Assessments Strategic assessments of major suppliers and nemerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview A. Major Blood Typing, Grouping and Infectious Disease Screening Tests B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers C. Major in Vitro Diagnostic Technologies And Their Potential Applications 1. Molecular Diagnostics 2. Monoclonal and Polyclonal Antibodies 3. Immunoassays 4. Microtitration Plates 5. IT and Automation 6. Lasers 7. Robotics 8. Synthetic Red Cell Substitutes 9. Genetically Engineered Blood Components 10. Blood Preservation 11. Autologous Blood Transfusion/Freezing III. Spain A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares for Blood Typing, Groupingand Infectious Disease Screening Tests IV. Major Product Development Opportunities A. Blood Typing and Grouping B. Infectious Disease Screening C. Auxiliary V. Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts VI. Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix: Assumed Currency Exchange Rates For more information visit http://www.researchandmarkets.com/research/lp...ransfusion
France Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies
M2 - Fri Sep 06, 8:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hf7js5/france) has announced the addition of the "France Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the French transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in France; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion diagnostic products by individual product. Competitive Assessments Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. Market Segmentation Analysis - Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and key suppliers. - Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT, by country and market segment: - Blood Centers - Hospitals - Commercial/Private Laboratories Current and Emerging Products - Analysis of current and emerging blood typing, grouping and infectious disease screening tests. - Review of automated and semi-automated analyzers. Key Topics Covered: I.Introduction II.Worldwide Technology and Market Overview III.France A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests IV.Major Product Development Opportunities A. Blood Typing and Grouping B. Infectious Disease Screening C. Auxiliary V.Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts VI.Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection VII.Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan XII. Appendix: Assumed Currency Exchange Rates For more information visit http://www.researchandmarkets.com/research/hf7js5/france
Germany Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies
M2 - Fri Sep 06, 8:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jhzmg8/germany) has announced the addition of the "Germany Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the German transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in Germany; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion diagnostic products by individual product. Competitive Assessments Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. Market Segmentation Analysis - Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and key suppliers. - Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT, by country and market segment: - Blood Centers - Hospitals - Commercial/Private Laboratories Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview III. Germany A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests IV. Major Product Development Opportunities A. Blood Typing and Grouping B. Infectious Disease Screening C. Auxiliary V. Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts VI. Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix: Assumed Currency Exchange Rates For more information visit http://www.researchandmarkets.com/research/jhzmg8/germany
Italy Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies
M2 - Fri Sep 06, 8:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gbmfl6/italy_transfusion) has announced the addition of the "Italy Transfusion Diagnostics Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the Italian transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in Italy; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion diagnostic products by individual product. Competitive Assessments Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview III. Italy A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests IV. Major Product Development Opportunities A. Blood Typing and Grouping B. Infectious Disease Screening C. Auxiliary V. Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts VI. Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan XII. Appendix: Assumed Currency Exchange Rates For more information visit http://www.researchandmarkets.com/research/gb...ransfusion
Global Transfusion Diagnostics Market 2013 - France, Germany, Italy, Japan, Spain, UK, USA - Sales Forecasts, Supplier Shares, Competitive Strategies
M2 - Fri Sep 06, 8:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fhzvtw/global) has announced the addition of the "Global Transfusion Diagnostics Market 2013 - France, Germany, Italy, Japan, Spain, UK, USA - Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in the US, Europe and Japan; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Geographic Regions - France - Germany - Italy - Japan - Spain - UK - USA Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview III. France IV. Germany A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests V. Italy A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests VI. Japan A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests VII. Spain A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers' Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests VIII. U.K. IX. U.S.A. X. Major Product Development Opportunities XI. Alternative Market Penetration Strategies XII. Potential Market Entry Barriers and Risks XIII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan XIV. Appendix: Assumed Currency Exchange Rates For more information visit http://www.researchandmarkets.com/research/fhzvtw/global
